Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000534354 | SCV000650940 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001564850 | SCV001788078 | uncertain significance | not provided | 2023-10-06 | criteria provided, single submitter | clinical testing | Reported in a patient with a history of sudden cardiac arrest in the published literature (PMID: 33652119); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 33652119) |
Ambry Genetics | RCV002448761 | SCV002733943 | uncertain significance | Cardiovascular phenotype | 2022-11-23 | criteria provided, single submitter | clinical testing | The p.R766W variant (also known as c.2296C>T), located in coding exon 15 of the FLNC gene, results from a C to T substitution at nucleotide position 2296. The arginine at codon 766 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002497174 | SCV002812703 | uncertain significance | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2021-08-23 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001564850 | SCV003833156 | uncertain significance | not provided | 2021-11-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001564850 | SCV004010722 | uncertain significance | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing |